NCT05773001View on ClinicalTrials.gov

Macrophage Regulation of Ozone-Induced Lung Inflammation

PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 18, 2023

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
SARS-CoV-2 Pneumonia
Interventions
DRUG

Ozone

Subjects will perform alternating 15 minutes rest with 15 minutes treadmill walk exercise periods for 135 minutes in while breathing Ozone (O3).

Trial Locations (1)

27710

RECRUITING

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Environmental Health Sciences (NIEHS)

NIH

lead

Robert Tighe, MD

OTHER